Edgewise Thera

$10.53 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Edgewise Thera

Edgewise Therapeutics, Inc. operates as a biotechnology company. The Company develops novel, transformative therapies for the treatment of patients with debilitating diseases. Edgewise Therapeutics serves customers in the State of Colorado.

Stock Analysis

last close $10.53
1-mo return 5.2%
3-mo return 41%
avg daily vol. 192.06T
52-week high 22.98
52-week low 5.41
market cap. $531M
forward pe -
annual div. -
roe -20.8%
ltg forecast -
dividend yield -
annual rev. $--
inst own. -

Subscribe now for daily local and international financial news